The impact of ganglion cell layer cysts in diabetic macular oedema treated with anti-vascular endothelial growth factor.

Ceklic, Lala; Huf, Wolfgang; Ebneter, Andreas; Wolf, Sebastian; Zinkernagel, Martin; Munk, Marion (2019). The impact of ganglion cell layer cysts in diabetic macular oedema treated with anti-vascular endothelial growth factor. Acta ophthalmologica, 97(8), e1041-e1047. Wiley 10.1111/aos.14137

[img] Text
Ceklic_et_al-2019-Acta_Ophthalmologica.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (559kB)

PURPOSE

To investigate the prevalence and impact of ganglion cell layer cysts (GCLC) in patients with diabetic macular oedema (DME) under continuous anti-vascular endothelial growth factor (VEGF) therapy.

METHODS

The clinical findings and spectral domain optical coherence devices of baseline visits and follow-up after 12-24 and 36 months of DME patients under continuous anti-VEGF therapy were retrospectively collected and analysed for the impact of GCLC cysts. Previously established prognostic parameters were also assessed.

RESULTS

A total of 110 eyes of 110 DME patients (mean age 64 ± 10 years) were included. At baseline, 17% eyes had GCLC. With GCLC, the best-corrected visual acuity (BCVA) improvement was in mean 8.4 ± 2.4 Early-Treatment-Diabetic-Retinopathy-Study (ETDRS) letters less over the course of 36 months compared to the group lacking GCLC (p = 0.0009). Eyes with GCLC showed 68 ± 23.4 μm less central retinal thickness (CRT) decrease than eyes lacking GCLC (p < 0.0001). In the linear mixed effect models including external limiting membrane disruption, disintegration of inner retinal layer and epiretinal membrane, GCLC remained a statistical significant factor for the outcome parameter CRT, but missed statistical significance for BCVA.

CONCLUSION

Ganglion cell layer cysts (GCLC) seem to impact outcome in DME in patients receiving long-term treatment. This prognostic factor warrants further evaluation in the context of already well-established outcome parameters.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Ophthalmology
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > Forschungsbereich Augenklinik > Forschungsgruppe Augenheilkunde

UniBE Contributor:

Ebneter, Andreas, Wolf, Sebastian (B), Zinkernagel, Martin Sebastian, Munk, Marion

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1755-3768

Publisher:

Wiley

Language:

English

Submitter:

Marion Munk

Date Deposited:

19 Jul 2019 09:24

Last Modified:

02 Mar 2023 23:32

Publisher DOI:

10.1111/aos.14137

PubMed ID:

31099498

Uncontrolled Keywords:

anti-VEGF cysts diabetic macular oedema retinal ganglion cell layer

BORIS DOI:

10.7892/boris.130740

URI:

https://boris.unibe.ch/id/eprint/130740

Actions (login required)

Edit item Edit item
Provide Feedback